…-diagnosis, when treatments may have their greatest impact on long-term outcomes in RRMS. Comment: Dr. Paul Giacomini, MD, FRCPC, Associate Director, MS Clinic, Montreal Neurological Hospital and Institute, Assistant Professor, Department of Neurology and Neurosurgery, McGill University, Montréal, Québec: The advent of new oral therapies, coupled with a greater understanding of MS pathophysiology, is certainly reshaping the way neurologists and th…